부산대학교 도서관

Carleton, Neil ; Nasrazadani, Azadeh ; Gade, Kristine ; Beriwal, Sushil ; Barry, Parul N ; Brufsky, Adam M ; Bhargava, Rohit ; Berg, Wendie A ; Zuley, Margarita L ; van Londen, G J ; Marroquin, Oscar C ; Thull, Darcy L ; Mai, Phuong L ; Diego, Emilia J ; Lotze, Michael T ; Oesterreich, Steffi ; McAuliffe, Priscilla F ; Lee, Adrian V

In The Lancet Healthy Longevity January 2022 3(1):e54-e66

Ivey, Abby D; Fagan, B Matthew; Murthy, Pranav; Lotze, Michael T; Zeh, Herbert J; Hazlehurst, Lori A; Geldenhuys, Werner J; Boone, Brian A

Clinical & Experimental Immunology. Mar2023, Vol. 211 Issue 3, p239-247. 9p.

Anderko RR; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Bowman AE; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Murthy P; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Murthy P; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Chopra A; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Tirukkovalur NV; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Ceuppens S; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Paniccia A; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.; Lee KK; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.; Mailliard RB; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Lotze MT; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.; Singhi AD; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.; Zureikat AH; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Dallal, Ramsey M ; Lotze, Michael T

In Current Opinion in Immunology 2000 12(5):583-588

Coukos G; University Hospital of Lausanne, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Gastman BR; Iovance Biotherapeutics, San Carlos, California, USA.; Goff SL; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Gros A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Harari A; University Hospital of Lausanne, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Hernandez S; University of California San Francisco, San Francisco, California, USA.; Ito F; University of Southern California, Los Angeles, California, USA.; Maker AV; University of California San Francisco, San Francisco, California, USA.; Mullinax JE; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.; Murthy P; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Pai SI; Yale University School of Medicine, New Haven, Connecticut, USA.; Prabhakaran S; University of New Mexico, UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.; Restifo NP; Medici Therapeutics, Boston, Massachusetts, USA.; Silver NL; Cleveland Clinic, Cleveland, Ohio, USA.; Marincola Smith P; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Turcotte S; Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.; Wagner PL; Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA.; Yang JC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Lotze MT; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Ramírez-Fernández Á; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Dimitri AJ; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Chen F; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Bartoszek R; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Chen GM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Córdoba-Espejo L; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Zhou Y; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Tang YH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lin CT; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Acosta R; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Ghilardi G; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Porazzi P; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Pellicer M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Profitós-Pelejà N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Chew A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Jadlowsky JK; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Gonzalez VE; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Siegel DL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Ruella M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Lotze MT; Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Riley JL; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Fraietta JA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.

Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE

Ellsworth SG; Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania.; Ross A; Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania.; Shiue KRY; Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.; Murthy P; Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania.; Byrne-Steel ML; iRepertoire, Inc., Huntsville, Alabama.; Patel R; Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania.; Zellars RC; Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.; Kong FS; Department of Clinical Oncology, Hong Kong University School of Clinical Medicine, Pokfulam Hong Kong SAR, China.; Miller A; Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.; Russ KA; Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.; Lotze MT; Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania.; Departments of Surgery, Immunology and Bioengineering; University of Pittsburgh; Pittsburgh, Pennsylvania.

Publisher: Radiation Research Society Country of Publication: United States NLM ID: 0401245 Publication Model: Print Cited Medium: Internet ISSN: 1938-5404 (Electronic) Linking ISSN: 00337587 NLM ISO Abbreviation: Radiat Res Subsets: MEDLINE

Olejniczak SH; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com.; Lotze MT; Departments of Surgery, Immunology, and Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com.; Skokos D; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Li C; Zhang Y; Cheng X; Yuan H; Zhu S; Liu J; Wen Q; Xie Y; Liu J; Kroemer G; Klionsky DJ; Lotze MT; Zeh HJ; Kang R; Tang D

Publisher: Cell Press Country of Publication: United States NLM ID: 101120028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1551 (Electronic) Linking ISSN: 15345807 NLM ISO Abbreviation: Dev Cell Subsets: MEDLINE; In Process

Lotze, Michael T; Kost, Thomas A

Cancer Gene Therapy. Aug2002, Vol. 9 Issue 8, p692. 8p.

Iwazawa, Takashi; Chau, Gar-Yang; Mori, Takahiro; Dookeran, Keith A; Rubin, Joshua T; Watkins, Simon; Robbins, Paul D; Lotze, Michael T; Tahara, Hideaki

Cancer Gene Therapy. Jan2001, Vol. 8 Issue 1, p17. 6p.

Okada, Hideho; Attanucci, Jason; Tahara, Hideaki; Pollack, Ian F; Bozik, Michael E; Chambers, William H; Lotze, Michael T

Cancer Gene Therapy. Mar2000, Vol. 7 Issue 3, p486. 9p.

Yurube T; Ferguson Laboratory for Orthopaedic and Spine Research, Department of Orthopaedic Surgery University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.; Department of Orthopaedic Surgery Kobe University Graduate School of Medicine Kobe Japan.; Buchser WJ; Damage Associated Molecular Pattern Molecule Laboratory, Department of Surgery, Hillman Cancer Center University of Pittsburgh Cancer Institute, University of Pittsburgh Pittsburgh Pennsylvania USA.; Zhang Z; Ferguson Laboratory for Orthopaedic and Spine Research, Department of Orthopaedic Surgery University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.; Department of Orthopaedic Surgery Kobe University Graduate School of Medicine Kobe Japan.; Silwal P; Ferguson Laboratory for Orthopaedic and Spine Research, Department of Orthopaedic Surgery University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.; Lotze MT; Damage Associated Molecular Pattern Molecule Laboratory, Department of Surgery, Hillman Cancer Center University of Pittsburgh Cancer Institute, University of Pittsburgh Pittsburgh Pennsylvania USA.; Kang JD; Ferguson Laboratory for Orthopaedic and Spine Research, Department of Orthopaedic Surgery University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.; Department of Orthopedics, Brigham and Women's Hospital, School of Medicine Harvard University Boston Massachusetts USA.; Sowa GA; Ferguson Laboratory for Orthopaedic and Spine Research, Department of Orthopaedic Surgery University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.; Department of Physical Medicine and Rehabilitation University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.; Vo NV; Ferguson Laboratory for Orthopaedic and Spine Research, Department of Orthopaedic Surgery University of Pittsburgh Medical Cancer, University of Pittsburgh Pittsburgh Pennsylvania USA.

Publisher: Wiley Periodicals, Inc Country of Publication: United States NLM ID: 101722350 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-1143 (Electronic) Linking ISSN: 25721143 NLM ISO Abbreviation: JOR Spine Subsets: PubMed not MEDLINE

Carleton N; Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA carletonn2@upmc.edu.; Lotze MT; Departments of Surgery, Immunology, and Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Ellsworth SG; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Abdelhakiem M; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Elgohari B; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Mohammed M; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Shogan J; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Vera A; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Burton SA; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Olson AC; 1Department of Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Lee KKW; 2Department of Surgery/Surgical Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Paniccia A; 2Department of Surgery/Surgical Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Zhang JY; 3Division of Oncology, Department of Medicine, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Lotze MT; 2Department of Surgery/Surgical Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; 4Department of Immunology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; 5Department of Bioengineering, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Zureikat AH; 2Department of Surgery/Surgical Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.

Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Buchbinder E; Dana-Farber Cancer Institute, Boston, Massachusetts, USA elizabeth_buchbinder@dfci.harvard.edu.; Lotze MT; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Margolin KA; Medical Oncology, City of Hope National Medical Center, Duarte, California, USA.; Amaria R; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sarnaik A; H Lee Moffitt Canc Ctr, Tampa, Florida, USA.; Seery V; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Eroglu Z; Moffitt Cancer Center, Tampa, Florida, USA.; Khaddour K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Betof Warner A; Stanford University School of Medicine, Stanford, California, USA.; Kluger HM; Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA.; Sznol M; Yale Cancer Center, Yale University, New Haven, Connecticut, USA.; Atkins MB; Oncology, Georgetown University, Washington, District of Columbia, USA.; Mcdermott DF; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Silk AW; Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Carleton N; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA.; Rosen ABI; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Das J; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Lotze MT; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Departments of Surgery and Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: lotzemt@upmc.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Gambotto, Andrea; Tüting, Thomas; McVey, Duncan L; Kovesdi, Imre; Tahara, Hideaki; Lotze, Michael T; Robbins, Paul D

Cancer Gene Therapy. Jan1999, Vol. 6 Issue 1, p45. 9p.

Tüting, Thomas; Gambotto, Andrea; DeLeo, Albert; Lotze, Michael T; Robbins, Paul D; Storkus, Walter J

Cancer Gene Therapy. Jan1999, Vol. 6 Issue 1, p73. 8p.

Cottrell TR; Queen's University Sinclair Cancer Research Institute, Kingston, Ontario, Canada trc3@queensu.ca.; Lotze MT; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Ali A; Stem Cell Transplant and Cellular Immunotherapy Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, Washington, DC, USA.; Bifulco CB; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.; Capitini CM; University of Wisconsin School of Medicine and Public Health and Carbone Cancer Center, Madison, Wisconsin, USA.; Chow LQM; The University of Texas at Austin, Austin, Texas, USA.; Cillo AR; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Collyar D; Patient Advocates In Research (PAIR), Danville, California, USA.; Cope L; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Deutsch JS; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Dubrovsky G; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Gnjatic S; Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Goh D; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore.; Halabi S; Duke School of Medicine and Duke Cancer Institute, Durham, North Carolina, USA.; Kohanbash G; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Maecker HT; Stanford University School of Medicine, Stanford, California, USA.; Maleki Vareki S; Department of Oncology and Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Mullin S; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Seliger B; Campus Brandenburg an der Havel, Brandenburg Medical School, Halle, Germany.; Taube J; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Vos W; Radiomics.bio, Liège, Belgium.; Yeong J; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore.; Anderson KG; Department of Microbiology, Immunology and Cancer Biology, Department of Obstetrics and Gynecology, Beirne B. Carter Center for Immunology Research and the University of Virginia Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USA.; Bruno TC; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Tumor Microenvironment Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Chiuzan C; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.; Diaz-Padilla I; GSK Oncology Research Unit, GSK, Baar, Zug, Switzerland.; Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Glitza Oliva IC; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Grandi P; Adze Biotech Inc, Cambridge, Massachusetts, USA.; Hill EG; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.; Hobbs BP; Dell Medical School, The University of Texas, Austin, Texas, USA.; Najjar YG; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Pettit Nassi P; University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA.; Simons VH; Prostate Net, Stanford, North Carolina, USA.; Subudhi SK; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sullivan RJ; Massachusetts General Hospital, Harvard Medical School, Needham, Massachusetts, USA.; Takimoto CH; IGM Biosciences, Mountain View, California, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE